Page 151 – Vaccine development: a challenging enterprise
Professor Stephen C Inglis
- Waye A, Jacobs P, Schryvers AB. Vaccine development costs: a review. Exp Rev Vaccines 2013;12:1495–1501.
- Hall AJ. The United Kingdom Joint Committee of Vaccination and Immunisation. Vaccine 2010;A54–A57.
- Reed SG. Vaccine adjuvants. Exp Rev Vaccines 2013;12:705–706.
- Department of Health and Social Care. Open consultation: cost effectiveness methodology for vaccination programmes. Published 26 February 2018. Available at: https://www.gov.uk/government/consultations/cost-effectiveness-methodology-for-vaccination-programmes
- The UK Vaccine R&D Network. Vaccine Development Process Map. Available at: www.vaccinedevelopment.org.uk